logo

Equity Analysis

NEWS
Gainers & Losers
Corporate Results - Detailed News
Syncom Formulations (India) standalone net profit declines 31.51% in the March 2022 quarter
19-May-22   08:06 Hrs IST
Net profit of Syncom Formulations (India) declined 31.51% to Rs 4.76 crore in the quarter ended March 2022 as against Rs 6.95 crore during the previous quarter ended March 2021. Sales declined 11.15% to Rs 58.23 crore in the quarter ended March 2022 as against Rs 65.54 crore during the previous quarter ended March 2021.

For the full year,net profit declined 32.16% to Rs 19.79 crore in the year ended March 2022 as against Rs 29.17 crore during the previous year ended March 2021. Sales declined 10.27% to Rs 219.66 crore in the year ended March 2022 as against Rs 244.81 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear Ended
 Mar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.
Sales58.2365.54 -11 219.66244.81 -10
OPM %3.2512.85 -8.8615.45 -
PBDT6.7011.99 -44 30.1144.70 -33
PBT5.6910.94 -48 26.1640.67 -36
NP4.766.95 -32 19.7929.17 -32

Powered by Capital Market - Live News